Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women: Neglected Populations at High Risk

Brandon Brown, Tonia Poteat, Logan Marg, Jerome T. Galea

Research output: Contribution to journalReview articlepeer-review

Abstract

Researchers and healthcare surveillance systems must clearly disaggregate data for transgender men and women from data for cisgender men and women to identify population-level health disparities and give every person an opportunity for cancer prevention. The limited human papillomavirus (HPV) vaccine recommendations for transgender men and women may be due to the scant literature on cancer prevalence coupled with poor understanding of HPV risks for these populations. Comprehensive cancer screening and prevention initiatives centered on relevant anatomy and sexual risk behaviors that are inclusive of transgender men and women are needed. Moreover, we need specific research to understand the impact of HPV and associated cancers on both transgender men's and women's lives.

Original languageEnglish (US)
Pages (from-to)315-319
Number of pages5
JournalLGBT health
Volume4
Issue number5
DOIs
StatePublished - Oct 2017

Keywords

  • HPV
  • HPV vaccine
  • cancer screening
  • gender identity
  • prevention
  • transgender

ASJC Scopus subject areas

  • Dermatology
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health
  • Urology

Fingerprint Dive into the research topics of 'Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening among Transgender Men and Women: Neglected Populations at High Risk'. Together they form a unique fingerprint.

Cite this